Introducing the HemaSphere Controversies Series

Dennis A Eichenauer^{1

2}, Jan Cools^{3

4}, Andreas Engert^{1

2}

Affiliations

¹ University of Cologne, First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Cologne, Germany.
² German Hodgkin Study Group (GHSG), First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.
³ Center for Human Genetics, KU Leuven, Leuven, Belgium.
⁴ Center for Cancer Biology, VIB, Leuven, Belgium.

Editorial

Dennis A Eichenauer et al. Hemasphere. 2019.

. 2019 Sep 27;3(5):e296.

doi: 10.1097/HS9.0000000000000296. eCollection 2019 Oct.

Dennis A Eichenauer^{1

2}, Jan Cools^{3

4}, Andreas Engert^{1

2}

¹ University of Cologne, First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Cologne, Germany.
² German Hodgkin Study Group (GHSG), First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany.
³ Center for Human Genetics, KU Leuven, Leuven, Belgium.
⁴ Center for Cancer Biology, VIB, Leuven, Belgium.

No abstract available

Conflict of interest statement

The authors have no conflicts of interest to disclose.

1. Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–3068. - PMC - PubMed
1. Dohner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–447. - PMC - PubMed
1. Schwab C, Harrison CJ. Advances in B-cell precursor acute lymphoblastic leukemia genomics. HemaSphere. 2018;2:e53. - PMC - PubMed
1. Cheson BD, Leonard JP. Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma. N Engl J Med. 2008;359:613–626. - PubMed
1. Younes A, Gopal AK, Smith SE, et al. Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. J Clin Oncol. 2012;30:2183–2189. - PMC - PubMed